These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 19811822)

  • 21. Growth inhibition and differentiation induction in human monoblastic leukaemia cells by 1alpha-hydroxyvitamin D derivatives and their enhancement by combination with hydroxyurea.
    Makishima M; Okabe-Kado J; Honma Y
    Br J Cancer; 1998; 77(1):33-9. PubMed ID: 9459143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperative effect of 1 alpha,25-dihydroxyvitamin D3 and dexamethasone in inducing differentiation of mouse myeloid leukemia cells.
    Miyaura C; Abe E; Honma Y; Hozumi M; Nishii Y; Suda T
    Arch Biochem Biophys; 1983 Dec; 227(2):379-85. PubMed ID: 6582801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of kinase suppressor of RAS-1(KSR-1) gene by 1, alpha25-dihydroxyvitamin D3 in human leukemia HL60 cells through a vitamin D response element in the 5'-flanking region.
    Wang X; Wang TT; White JH; Studzinski GP
    Oncogene; 2006 Nov; 25(53):7078-85. PubMed ID: 16732322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro suspension culture reactions to 1,25 dihydroxyvitamin D3 in relation to bone marrow morphology and prognosis in patients with myelodysplastic syndromes.
    Hellström-Lindberg E; Robèrt KH; Ahnsén B; Elmhorn-Rosenborg A; Kock Y; Ost A
    Leuk Res; 1992; 16(5):529-35. PubMed ID: 1625479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of idarubicin-induced apoptosis in human acute myeloid leukemia blasts by all-trans retinoic acid, 1,25(OH)2 vitamin D3, and granulocyte-macrophage colony-stimulating factor.
    Ketley NJ; Allen PD; Kelsey SM; Newland AC
    Blood; 1997 Dec; 90(11):4578-87. PubMed ID: 9373269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1 alpha,25-Dihydroxy-20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro.
    Elstner E; Lee YY; Hashiya M; Pakkala S; Binderup L; Norman AW; Okamura WH; Koeffler HP
    Blood; 1994 Sep; 84(6):1960-7. PubMed ID: 8080998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
    Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
    Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D(3)-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D(3) receptor.
    Ward JO; McConnell MJ; Carlile GW; Pandolfi PP; Licht JD; Freedman LP
    Blood; 2001 Dec; 98(12):3290-300. PubMed ID: 11719366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1,25-Dihydroxyvitamin D3 induces monocytic differentiation of human myeloid leukemia cells by regulating C/EBPβ expression through MEF2C.
    Zheng R; Wang X; Studzinski GP
    J Steroid Biochem Mol Biol; 2015 Apr; 148():132-7. PubMed ID: 25448741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1,25-Dihydroxyvitamin D3 induces monocytic differentiation of the PLB-985 leukemic line and promotes c-fgr mRNA expression.
    Perkins SL; Link DC; Kling S; Ley TJ; Teitelbaum SL
    J Leukoc Biol; 1991 Nov; 50(5):427-33. PubMed ID: 1660912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1alpha,25-dihydroxyvitamin D(3)-26,23-lactone analogs antagonize differentiation of human leukemia cells (HL-60 cells) but not of human acute promyelocytic leukemia cells (NB4 cells).
    Miura D; Manabe K; Gao Q; Norman AW; Ishizuka S
    FEBS Lett; 1999 Oct; 460(2):297-302. PubMed ID: 10544253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloid maturation potentiates STAT3-mediated atypical IFN-γ signaling and upregulation of PD-1 ligands in AML and MDS.
    Yoyen-Ermis D; Tunali G; Tavukcuoglu E; Horzum U; Ozkazanc D; Sutlu T; Buyukasik Y; Esendagli G
    Sci Rep; 2019 Aug; 9(1):11697. PubMed ID: 31406210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The vitamin D receptor-mediated activation of phosphatidylinositol 3-kinase (PI3Kalpha) plays a role in the 1alpha,25-dihydroxyvitamin D3-stimulated increase in steroid sulphatase activity in myeloid leukaemic cell lines.
    Hughes PJ; Lee JS; Reiner NE; Brown G
    J Cell Biochem; 2008 Apr; 103(5):1551-72. PubMed ID: 17879954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model.
    Nachliely M; Trachtenberg A; Khalfin B; Nalbandyan K; Cohen-Lahav M; Yasuda K; Sakaki T; Kutner A; Danilenko M
    J Steroid Biochem Mol Biol; 2019 Apr; 188():8-16. PubMed ID: 30508646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional defect of variant clones of a human myeloid leukemia cell line (HL-60) resistant to 1 alpha,25-dihydroxyvitamin D3.
    Kuribayashi T; Tanaka H; Abe E; Suda T
    Endocrinology; 1983 Dec; 113(6):1992-8. PubMed ID: 6315339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of mTORC1 by RAD001 (everolimus) potentiates the effects of 1,25-dihydroxyvitamin D(3) to induce growth arrest and differentiation of AML cells in vitro and in vivo.
    Yang J; Ikezoe T; Nishioka C; Ni L; Koeffler HP; Yokoyama A
    Exp Hematol; 2010 Aug; 38(8):666-76. PubMed ID: 20382200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monocytic differentiation of acute promyelocytic leukemia cells in response to 1,25-dihydroxyvitamin D3 is independent of nuclear receptor binding.
    Bhatia M; Kirkland JB; Meckling-Gill KA
    J Biol Chem; 1995 Jul; 270(27):15962-5. PubMed ID: 7608152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The rationale for deltanoids in therapy for myeloid leukemia: role of KSR-MAPK-C/EBP pathway.
    Studzinski GP; Wang X; Ji Y; Wang Q; Zhang Y; Kutner A; Harrison JS
    J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):47-55. PubMed ID: 16046262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological activity of 24,24-difluoro-1 alpha, 25-dihydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3-26,23-lactone in inducing differentiation of human myeloid leukemia cells.
    Shiina Y; Abe E; Miyaura C; Tanaka H; Yamada S; Ohmori M; Nakayama K; Takayama H; Matsunaga I; Nishii Y; DeLuca HF; Suda T
    Arch Biochem Biophys; 1983 Jan; 220(1):90-4. PubMed ID: 6572492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS/RAF/ERK-MAP kinase signalling pathway.
    Hughes PJ; Brown G
    J Cell Biochem; 2006 Jun; 98(3):590-617. PubMed ID: 16440327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.